|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0038952,
umls-concept:C0085862,
umls-concept:C0138741,
umls-concept:C0205474,
umls-concept:C0231174,
umls-concept:C0376358,
umls-concept:C0430420,
umls-concept:C1299583,
umls-concept:C1522449,
umls-concept:C1549571,
umls-concept:C1550147,
umls-concept:C1608386,
umls-concept:C2698872
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-11-2
|
|
pubmed:abstractText |
To assess the impact of pretreatment prognostic factors plus subsequent biochemical failure on overall survival after radiotherapy for prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1082-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15519778-Adult,
pubmed-meshheading:15519778-Aged,
pubmed-meshheading:15519778-Aged, 80 and over,
pubmed-meshheading:15519778-Humans,
pubmed-meshheading:15519778-Male,
pubmed-meshheading:15519778-Middle Aged,
pubmed-meshheading:15519778-Prognosis,
pubmed-meshheading:15519778-Proportional Hazards Models,
pubmed-meshheading:15519778-Prostate-Specific Antigen,
pubmed-meshheading:15519778-Prostatic Neoplasms,
pubmed-meshheading:15519778-Statistics, Nonparametric,
pubmed-meshheading:15519778-Survival Analysis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer.
|
|
pubmed:affiliation |
William Buckland Radiotherapy Centre and Monash University, Melbourne, Australia. scott.williams@wbrc.org.au
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
